Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Remicade Anti-Competitive Pricing

The UK Competition and Markets Authority (CMA) issued a statement of objections to Merck subsidiary Merck Sharp & Dohme Limited (MSD) with regard to the pricing of its anti-inflammatory drug Remicade. The CMA provisionally found that MSD broke competition law by abusing its dominant position through a discount scheme for Remicade that was likely to restrict competition for biosimilar versions.

Misconduct Type
Antitrust
Enforcement Agency
International
Contracting Party
None
Court Type
Administrative
Disposition
Pending
Date of CMA Provisional Decision
5/23/2017
Contractors Involved Penalty
Total
Merck & Co., Inc. $0
Further Information Released
CMA Press Release 5/23/2017

Federal Contractor Misconduct Database